Silo Pharma, Inc. Common Stock Stock Prediction
AI-powered sentiment analysis and prediction trends for SILO, updated each market day.
SILO AI Sentiment
AI predicts Silo Pharma, Inc. Common Stock stock is likely to decrease over the next 10 market days.
Prediction date: April 10, 2026
Subscribers see precise scores, buy/sell targets, and full analytics.
About Silo Pharma, Inc. Common Stock
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's portfolio includes programs such as SPC-15 for PTSD, SP-26 for fibromyalgia and chronic pain, and preclinical assets targeting Alzheimer's disease and multiple sclerosis. The company's product pipelines include: SPC-14, SPC-15, SP-26, and SPU-16. The company operates as a single operating segment as a clinical-stage biopharmaceutical company focused on developing new generation therapies for unmet medical need.
Sector
Exchange
Market Cap
$6,765,276
Cap Tier
Employees
3
Headquarters
SARASOTA, FL
Listed Since
Jan. 5, 2012
Website
SILO Sentiment Trend — Last 30 Predictions
Sentiment zones: Bullish · Neutral · Bearish
SILO Volatility
Silo Pharma, Inc. Common Stock has shown high price volatility over the last 5 trading days. High volatility means larger price swings — this can present both opportunity and risk for traders.
